secwatch.observer — SEC 8-K summary
======================================

Issuer:     Guardian Pharmacy Services, Inc. (GRDN)
CIK:        0001802255
Form:       8-K
Filed at:   2024-11-12T23:59:59+00:00
Accession:  0001193125-24-255981
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Guardian Pharmacy Q3 revenue $314M (+20% YoY); Adj. EBITDA $23M (+20%); guides FY24
--------------------------------------------------------------------------------

- Revenue of $314.4M (+20% YoY) driven by organic growth and Heartland Pharmacy acquisition.
- Net loss of $105.8M due to $122.4M share-based comp from IPO; Adj. EBITDA of $23.0M (+20% YoY).
- Resident count of 180,000 at quarter-end, up 12% YoY.
- FY 2024 guidance: revenue $1.205B-$1.215B, Adjusted EBITDA $86.5M-$87.0M.
- Completed a small acquisition in Q3, entering a new market with a strong operating team.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1802255/000119312524255981/0001193125-24-255981-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1802255/000119312524255981/d895150d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-255981

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer